RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
  AIIMS
  Madhya Pradesh
  Medical Tourism
  Orissa Healthcare
  Maharashtra
  Bihar
  Uttar Pradesh Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
India Healthcare Channel

subscribe to India Healthcare newsletter
Healthcare : India Healthcare

   EMAIL   |   PRINT
Biotech industry hails tax sops in Indian budget

Mar 1, 2010 - 8:56:10 PM
According to Manipal Health Systems chief executive Rajen Padukone, relaxation of FDI - norms will result in more international players entering the healthcare sector.

 
[RxPG] Bangalore, Feb 26 - The biotechnology industry Friday welcomed the slew of incentives and tax reliefs proposed in the union Budget for the ensuing fiscal 2010-11.

'Though we need to read the fine-print for details, we thank the finance minister for responding to some of our concerns, especially for raising the weighted deduction on all in-house R&D - to 200 percent from 150 percent,' Biocon chairperson Kiran Mazumdar told IANS here.

As significant part of the R&D budget is not in-house, the industry hopes the benefit would apply to costs incurred on filing international patents for protecting the IP - and conducting clinical trials outside the country.

'The increased deduction should allow us to claim international patenting cost and in licensing technology. Otherwise, it will not be helpful. The government needs to be little more insightful than making cosmetic changes,' Mazumdar said.

The Association of Biotechnology led Enterprises - also said legitimate R&D expenses need to be covered under the weighted deduction scheme.

Lauding the service tax exemption on testing and certification of seeds, the association said the concessions extended to medical devices and equipment industry would benefit the healthcare sector in reducing the end-costs.

The budget has proposed concessional basic duty of five percent, CVD - of four percent and zero special additional duty on medical equipment. Specified inputs for manufacturing orthopedic implants are also exempted from import duty.

'The complete liberalisation of pricing and payment of technology transfer fee, trademark, and brand name and royalty payments will augur well to attract fresh investments in the sunrise industry,' the association said in a statement.

The association, however, termed the three percent increase in minimum alternative tax - rate to 18 percent as a negative signal when all other taxes were being reduced.

In a related development, Fortis Hospitals chief executive Vishal Bali regretted that the budget had ignored the call for reforming the Indian healthcare.

'Though the budget has a whopping 46 percent of plan allocation for infrastructure development, not finding healthcare on the finance minister's agenda takes another year away in bridging the affordability and accessibility gap in the sector,' Bali said in a statement here.

'The only positive step to help indigenous manufacture of consumables and implants is the import duty waiver for manufacture of orthopedic implants,' Bali noted.

According to Manipal Health Systems chief executive Rajen Padukone, relaxation of FDI - norms will result in more international players entering the healthcare sector.

'Extension of tax benefits on contribution to central government health scheme - will attract more funds to the scheme and improve its operations substantially,' Padukone said in a statement.




Advertise in this space for $10 per month. Contact us today.


Related India Healthcare News
Stigma preventing leprosy-cured from getting jobs
Melinda Gates calls on Akhilesh Yadav
'Movies, TV impact tobacco users more than newspapers'
Rockland to open three new hospitals in NCR
Spice Global enters healthcare business with hospital in Delhi
Delhi to expedite recruitment of doctors
Sex selective abortion rampant in Delhi, says study
AIIMS-II launched in Haryana village
Delhi hospital launches helpline for strokes
Free health screening for school children Nov 14

Subscribe to India Healthcare Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)